1. |
Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease[J].Curr Opin Immunol, 2009, 21(1): 38-46. DOI:10.1016/j.coi.2009.01.009.
|
2. |
Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes[J]. J Immunol, 2000, 164: 4991-4995.
|
3. |
Sieber MW, Jaenisch N, Brehm M, et al. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2(TREM2) knock-out mice following stroke[J/OL]. PLoS One, 2013, 8(1): 52982[2013-01-03] . https://doi.org/10.1371/journal.pone.0052982. DOI:10.1371/journal.pone.0052982.
|
4. |
Takahashi K, Rochford CDP, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2[J]. Exp Med, 2005, 201(4): 647-657. DOI:10.1084/jem.20041611.
|
5. |
Kawabori M, Kacimi R, Kauppinen T, et al. Triggering receptor expressed on myeloid cells 2(TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke[J]. J Neurosci, 2015, 35(8): 3384-3396. DOI:10.1523/JNEUROSCI. 2620-14.2015.
|
6. |
Peng Q, Malhotra S, Torchia JA, et al. TREM2-and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1[J]. Sci Signal, 2010, 3(122): 38.DOI: 10.1126/scisignal.2000500.
|
7. |
Colonna M. TREMs in the immune system and beyond[J]. Nat Rev Immunol,2003, 3(6): 445- 453. DOI: 10.1038/nri1106.
|
8. |
Colonna M, Facchetti F. TREM-1(triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses[J].J Infect Dis, 2003, 187 Suppl 2:S397-401. DOI:10.1086/374754.
|
9. |
Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection[J]. Immunobiology, 2008, 213(9-10): 701-713. DOI:10.1111/jre.12417.
|
10. |
Fahrenhold M, Rakic S, Classey J,et al.TREM2 expression in the human brain: a marker of monocyte recruitment?[J/OL].Brain Pathol,2017,2017:E1[2017-10-07] .https://doi.org/10.1111/bpa.12564. DOI: 10.1111/bpa.12564.[published online ahead of print].
|
11. |
.Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response[J]. J Immunol, 2003,170(7): 3812-3818.
|
12. |
Knapp S, Gibot S, de Vos A, et al. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia[J].J Immunol,2004,173(12): 7131-7134.
|
13. |
Hiroyuki K, Hiroshi K. Microglial TREM2/DAP12 signaling: a double-edged sword in neural diseases[J]. Front Cell Neurosci, 2018, 12:206. DOI:org/10.3389/fncel.2018.00206.
|
14. |
Jeremie J, Stephane P, Lynda Z, et al. Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis[J]. J Am Coll Cardiol, 2016,68(25): 2776-2793. DOI:10.1016/j.jacc.2016.10.015.
|
15. |
Ma Y,Wang J,Wang Y, et al. The biphasic function of microglia in ischemic stroke[J]. Prog Neurobiol, 2017, 157: 247-272. DOI:10.1016/j.pneurobio.2016.01.005.
|